SCHEMBL27452291

SCHEMBL27452291

O=C(CCCc1cnco1)Nc1ccc(Cc2nc3ccccc3s2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.60
▸ MAPT P10636 5/20 0.55
▸ NAMPT P43490 2/20 0.53
▸ POLB P06746 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ ALDH1A1 P00352 4/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ PKM P14618 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HTT P42858 2/20 0.48
▸ HPGD P15428 3/20 0.48
▸ ATM Q13315 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.47
▸ KLF5 Q13887 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27452284 0.87 NAMPT (0.69) LMNAMAPTNAMPTPOLBMEN1
SCHEMBL27452211 0.83 HTT (0.64) LMNAMAPTNAMPTPOLBMEN1
SCHEMBL27452495 0.82 NAMPT (0.54) LMNAMAPTNAMPTPOLBMEN1
SCHEMBL27451212 0.81 NAMPT (0.71) MAPTNAMPTPOLBMEN1KMT2A
SCHEMBL27452347 0.79 NAMPT (0.51) LMNAMAPTNAMPTPOLBMEN1
SCHEMBL27452429 0.77 LMNA (0.59) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL6034952 0.76 LMNA (1.00) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL27453115 0.75 LMNA (0.56) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL27452286 0.75 NAMPT (0.55) MAPTNAMPTPOLBMEN1KMT2A
SCHEMBL27452151 0.71 MEN1 (0.61) LMNAMAPTNAMPTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145662-A1 2-SUBSTITUTED THIAZOLE AND BENZOTHIAZOLE COMPOSITIONS AND METHODS AS DUX4 INHIBITORS ALTAY THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback